GNW
Genworth Financial, Inc.Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the U
2-Year Price History
Quarterly Financials & Projections
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Est | 2028-Q1 | 1,740 | 121.8 | -- | 60.9 | -- | 87.0 | -0.0 | 47,891 | -- | -- | -- | -- | -- |
| Est | 2027-Q4 | 1,660 | 58.1 | -- | 16.6 | -- | 58.1 | -0.0 | 47,804 | -- | -- | -- | -- | -- |
| Est | 2027-Q3 | 1,800 | 162.0 | -- | 81.0 | -- | 135.0 | -0.0 | 47,746 | -- | -- | -- | -- | -- |
| Est | 2027-Q2 | 1,730 | 129.8 | -- | 60.6 | -- | 51.9 | -0.0 | 47,611 | -- | -- | -- | -- | -- |
| Est | 2027-Q1 | 1,760 | 132.0 | -- | 70.4 | -- | 88.0 | -0.0 | 47,559 | -- | -- | -- | -- | -- |
| Est | 2026-Q4 | 1,680 | 67.2 | -- | 25.2 | -- | 67.2 | -0.0 | 47,471 | -- | -- | -- | -- | -- |
| Est | 2026-Q3 | 1,820 | 172.9 | -- | 81.9 | -- | 127.4 | -0.0 | 47,404 | -- | -- | -- | -- | -- |
| Est | 2026-Q2 | 1,750 | 140.0 | -- | 61.3 | -- | 61.3 | -0.0 | 47,276 | -- | -- | -- | -- | -- |
| Act | 2026-Q1 | 1,723 | 136.0 | 111.0 | 47.0 | 91.0 | 91.0 | -0.0 | 47,215 | 1,509 | 393.7 | 11.6% | 5.4x | -- |
| Act | 2025-Q4 | 1,493 | 44.0 | 18.0 | 2.0 | 200.0 | 200.0 | -0.0 | 2,036 | 1,546 | 396.4 | 2.0% | 1.7x | 5.9x |
| Act | 2025-Q3 | 1,873 | 191.0 | 164.0 | 116.0 | 87.0 | 87.0 | -0.0 | 48,146 | 1,520 | 413.3 | 22.1% | 7.1x | -- |
| Act | 2025-Q2 | 1,727 | 151.0 | 125.0 | 51.0 | 6.0 | 6.0 | -0.0 | 47,469 | 1,520 | 417.5 | 12.9% | 5.8x | -- |
| Act | 2025-Q1 | 1,778 | 152.0 | 126.0 | 54.0 | 34.0 | 34.0 | -0.0 | 7,695 | 1,519 | 422.9 | 13.2% | 5.8x | -- |
| Act | 2024-Q4 | 1,722 | 82.0 | 55.0 | -1.0 | 27.0 | 27.0 | -0.0 | 7,720 | 1,518 | 431.0 | 5.7% | 3.0x | -- |
| Act | 2024-Q3 | 1,844 | 189.0 | 161.0 | 85.0 | 161.0 | 161.0 | -0.0 | 7,747 | 1,548 | 435.8 | 20.2% | 6.8x | -- |
| Act | 2024-Q2 | 1,733 | 173.0 | 143.0 | 76.0 | 7.0 | 7.0 | -0.0 | 7,581 | 1,564 | 440.7 | 17.3% | 5.8x | -- |
| Act | 2024-Q1 | 1,844 | 266.0 | 236.0 | 139.0 | -107.0 | -107.0 | -0.0 | 7,737 | 1,579 | 450.3 | 31.7% | 8.9x | -- |
| Act | 2023-Q4 | 1,870 | -187.0 | -217.0 | -212.0 | 147.0 | 147.0 | -0.0 | 48,996 | 1,584 | 449.4 | -44.6% | -6.2x | -- |
| Act | 2023-Q3 | 1,800 | 120.0 | 90.0 | 29.0 | 175.0 | 261.0 | -86.0 | 8,018 | 1,602 | 466.0 | 10.8% | 4.0x | -- |
| Act | 2023-Q2 | 1,875 | 250.0 | 221.0 | 137.0 | 258.0 | 258.0 | -0.0 | 8,380 | 1,601 | 478.1 | 40.8% | 8.6x | -- |
| Act | 2023-Q1 | 1,826 | 238.0 | 209.0 | 122.0 | 17.0 | 17.0 | -0.0 | 49,133 | 1,600 | 500.1 | 38.5% | 8.2x | -- |
| Act | 2022-Q4 | 1,873 | 288.0 | 260.0 | 175.0 | 404.0 | 404.0 | -0.0 | 48,382 | 1,611 | 503.2 | 50.6% | 10.3x | -- |
| Act | 2022-Q3 | 1,810 | 246.0 | 220.0 | 136.0 | 308.0 | 308.0 | -0.0 | 48,050 | 1,622 | 509.4 | 40.9% | 9.5x | -- |
| Act | 2022-Q2 | 1,855 | 286.0 | 260.0 | 159.0 | 429.0 | 429.0 | -0.0 | 51,253 | 1,773 | 514.2 | 20.9% | 11.0x | -- |
| Act | 2022-Q1 | 1,851 | 317.0 | 291.0 | 191.0 | -92.0 | -92.0 | -0.0 | 56,548 | 1,819 | 517.4 | 13.7% | 12.2x | -- |
Multiples vs the company's own history — cheap or rich relative to itself? Historical fiscal years, then TTM, then forward projections (E). Forward rows hold today's price against projected earnings, so the multiple compresses if the company grows into it.
| Year | Price | Rev Gr | EBITDA % | EBITDA | EV/EBITDA | EV/FCF | P/E | P/S |
|---|---|---|---|---|---|---|---|---|
| 2022 | 5.29 | — | 15.4% | 1,137 | — | — | 2.8× | 0.3× |
| 2023 | 6.68 | -0.2% | 5.7% | 421 | — | — | 35.1× | 0.4× |
| 2024 | 6.99 | -3.1% | 9.9% | 710 | — | — | 9.7× | 0.4× |
| 2025 | 9.03 | -3.8% | 7.8% | 538 | 5.9× | 9.7× | 16.4× | 0.5× |
| TTM | 8.56 | -3.7% | 7.7% | 522 | — | — | 0.0× | 0.0× |
| 2027E | 8.56 | +2.0% | 0.1% | 5 | — | — | 0.0× | 0.0× |
EBITDA in reporting-currency $M. Historical multiples use year-end market cap (split-adjusted price history); TTM & forward years use today's.
AI Analysis
LLM Evaluations
Genworth is a complex, show-me story that hinges on Enact's mortgage insurance profitability funding aggressive share repurchases while the legacy LTC closed block slowly runs off. At ~$9.20/share, the stock prices in moderate success: Enact is worth roughly $5.5-6.0B but GNW only owns 81%, and the $3.1B unrealized loss overhang plus ~$300M/year in Closed Block A/E losses create persistent drags. The -6.9% annual dilution (actually share reduction from buybacks) is a tailwind, but earnings are declining structurally as the legacy blocks deteriorate. CareScout is a promising but unproven pivot that won't move the needle for several years. The AXA litigation represents significant option value ($750M potential) but is binary and timing-uncertain. The stock is roughly fairly valued — cheap on a P/FCF basis but the quality of earnings is poor and the tail risks (RBC deterioration, commercial real estate losses, regulatory pushback on LTC rate increases) are real.
Latest Earnings Call
Transcript Summary
Genworth Financial's Q1 2026 earnings call highlighted a strategic reporting shift to emphasize its core growth segments, Enact and CareScout, by excluding the volatile closed block from primary adjusted operating income. The company reported a net income of $47 million, bolstered by Enact’s robust $140 million adjusted operating income. Enact continues to provide significant cash flow, enabling Genworth to return capital through share repurchases—totaling $875 million since the program's start—and opportunistic debt retirement. CareScout, the company’s aging care services platform, is scaling rapidly, having facilitated 1,500 matches in the quarter and expanding into senior living communities. Management remains confident in reaching 7,500 matches and $25 million in service revenue for 2026. Meanwhile, the closed block is managed for self-sustainability through the Multi-Year Rate Action Plan, which has generated $34.5 billion in net present value since 2012. In the Q&A, management addressed concerns regarding the statutory RBC ratio, asserting that levels remain comfortably above regulatory thresholds despite seasonal mortality pressure. They also clarified that their private credit exposure is predominantly investment-grade. With a potential $750 million recovery from Absa litigation pending appeal, Genworth maintains a strong liquidity position and a disciplined focus on long-term shareholder value.
Valuation & Metrics
Market Stats
TTM Financial Snapshot
DCF Fair Value Estimate
Forward Outlook & Risk
Short Interest
Options
| Strike | Call Bid/Ask | Call OI | Put Bid/Ask | Put OI |
|---|---|---|---|---|
| $6.00 | $2.70/$3.90 | 0 | --/$0.75 | 0 |
| $7.00 | $1.75/$2.70 | 0 | --/$0.75 | 0 |
| $8.00 | $0.80/$1.75 | 2 | --/$0.75 | 0 |
| $9.00 | --/$0.90 | 0 | --/$0.75 | 0 |
| $10.00 | --/$0.30 | 5 | $0.45/$1.40 | 0 |
| $11.00 | --/$0.75 | 0 | $1.35/$2.30 | 0 |
| $12.00 | --/$0.75 | 0 | $2.10/$3.30 | 0 |
| $13.00 | --/$0.75 | 0 | $3.10/$4.30 | 0 |
Forward Projections & Estimates
Employees
Institutional Ownership
Headline & net flow
In Q1 2026 so far (quarter still filing), institutions are net buyers — bought 6.0% of float, sold 3.5%.
Ownership composition
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| BlackRock, Inc.Passive | $462M | $6.87 | −$12.9M | −$37.5M | -0.2% | $5.69T |
| DIMENSIONAL FUND ADVISORS LPPassive | $207M | $4.52 | −$305K | −$15.1M | -0.4% | $480.92B |
| DONALD SMITH & CO., INC. | $207M | $5.05 | +$13.9M | −$13.2M | +3.3% | $5.56B |
| VANGUARD PORTFOLIO MANAGEMENT LLCPassive | $190M | $8.12 | +$190M | +$190M | — | $1.91T |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $144M | $8.12 | +$144M | +$144M | — | $4.04T |
| STATE STREET CORPPassive | $134M | $4.99 | −$4.7M | −$28.8M | -0.2% | $2.89T |
| River Road Asset Management, LLC | $124M | $4.43 | −$8.7M | −$14.3M | -0.7% | $8.82B |
| AMERICAN CENTURY COMPANIES INC | $90.0M | $6.49 | +$5.7M | +$24.6M | +0.7% | $193.48B |
| Nuveen, LLC | $81.9M | $8.26 | +$2.4M | +$53.6M | +0.0% | $368.63B |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $80.9M | $5.61 | +$496K | −$2.0M | +2.3% | $1.61T |
| GENDELL JEFFREY L | $62.5M | $8.85 | +$9.8M | +$62.5M | +8.4% | $7.34B |
| FMR LLC | $62.3M | $5.97 | +$1.9M | +$4.0M | -0.0% | $1.89T |
| D. E. Shaw & Co., Inc. | $47.8M | $7.20 | +$1.7M | +$31.5M | -0.3% | $118.02B |
| NORTHERN TRUST CORPPassive | $42.6M | $6.23 | +$629K | −$5.2M | -0.2% | $755.34B |
| CITADEL ADVISORS LLC | $42.5M | $7.25 | +$6.6M | +$30.6M | -0.4% | $138.22B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $38.2M | $5.87 | −$1.4M | −$4.5M | +0.7% | $645.81B |
| MORGAN STANLEY | $31.8M | $6.45 | −$6.3M | −$6.1M | -0.3% | $1.65T |
| Invesco Ltd. | $26.4M | $5.97 | −$1.5M | +$1.7M | -0.2% | $652.04B |
| Whitefort Capital Management, LP | $25.4M | $5.50 | +$4.8M | +$1.2M | -0.7% | $317M |
| Man Group plc | $21.9M | $5.91 | +$13.3M | +$15.0M | -0.4% | $47.62B |
Trading behavior
▸ Compare to holder-profile behavior (across all their stocks)
Biggest decreases this quarter
New buyers this quarter
Top-5 holders · 44.8%
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
Analyst Coverage
| Quarter | Revenue | EBITDA | Net Inc | EPS | EPS Range | # Analysts |
|---|---|---|---|---|---|---|
| 2023 Q1 | 1.9B | 215M | 138M | $0.20 | $0.20 – $0.20 | 1 |
| 2023 Q2 | 1.9B | 217M | 140M | $0.20 | $0.20 – $0.20 | 1 |
| 2023 Q3 | 2.0B | 259M | 3.2B | $0.22 | $0.19 – $0.25 | 2 |
| 2023 Q4 | 2.0B | 224M | 142M | $0.19 | $0.19 – $0.19 | 1 |
| 2025 Q3 | 1.9B | 247M | 41M | $0.10 | $0.10 – $0.10 | 1 |
| 2025 Q4 | 1.5B | 186M | 63M | $0.16 | $0.16 – $0.16 | 1 |
| 2026 Q1 | 1.7B | 214M | 69M | $0.17 | $0.17 – $0.17 | 1 |
| 2026 Q2 | 1.7B | 212M | 37M | $0.10 | $0.10 – $0.10 | 1 |
| 2026 Q3 | 1.7B | 210M | 31M | $0.08 | $0.08 – $0.08 | 1 |
| 2026 Q4 | 1.7B | 207M | 28M | $0.07 | $0.07 – $0.07 | 1 |
Corporate
Executive Compensation (2021-2023)
Insider Trading (last 12mo)
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2025-12-02 | SELL | McInerney Thomas J | director, officer: President and CEO; Director | 40,000 | $8.64 | $346K | $44.13M |
| 2025-11-24 | SELL | Karawan Gregory S. | officer: EVP and General Counsel | 40,000 | $8.51 | $340K | $2.57M |
| 2025-08-27 | SELL | Gupta Rohit | officer: President & CEO, Enact | 86,406 | $8.68 | $750K | $6.90M |
Order Flow (FINRA, ~3w lag)
Revenue Breakdown
Revenue Segments
| Life and Annuities Segment | $413.0M | -4% |
| Australia Mortgage Insurance | $118.0M | -10% |
| Other Countries Mortgage Insurance | $7.0M | -22% |
Filing Risk Analysis
Filing Risk Scores
Genworth Financial: The Unrealized Loss Time Bomb Behind the Buyback Veil
Counter-Thesis
Counter-Thesis & Recent News
Genworth reported a Q1 2026 net income of $47M, significantly propped up by its Enact subsidiary, while its legacy 'Closed Block' (LTC and life insurance) posted an adjusted operating loss of $32M. A major headwind is the upcoming UK Court of Appeals hearing (July 21-23, 2026) regarding the long-standing AXA litigation over mis-selling liabilities. Furthermore, the U.S. 4th Circuit Court of Appeals recently ordered the company to respond to a petition for a full-court rehearing in Trauernicht v. Genworth, a 401(k) fiduciary breach class action that could reopen significant liability risks (Source: AM Best, PlanAdviser, May 2026).
The bear case centers on deteriorating profitability and a valuation disconnect. Net profit margins have contracted to 3% from 4.2% YoY, and earnings have declined at an annual rate of 35.3% over the last five years. Despite this, GNW trades at a P/E of ~15.5x, which is higher than the insurance industry average of 11.3x. Skeptics point to a DCF-implied fair value of approximately $1.63—over 80% below the current market price of ~$9.20. Management also expects 'Actual-vs-Expected' (A/E) losses in the Closed Block to hit $300M for the full year 2026 (Source: Simply Wall St, Seeking Alpha).
Significant statutory pressure has driven the GLIC consolidated Risk-Based Capital (RBC) ratio down to 289% following a $77M pre-tax statutory loss in Q1 2026. Short interest in the life insurance sector has more than doubled recently due to opaque private credit exposures. Additionally, major institutional selling has been observed; JPMorgan slashed its GNW position by 32% in late 2025, and Vanguard trimmed holdings by nearly 1.8M shares in Q4 2025. A notable downgrade to 'Sell' was issued by Wall Street Zen in February 2026 (Source: MarketBeat, Reuters, Perplexity).
In its core Enact mortgage insurance segment, Genworth faces extreme customer concentration, with its largest client accounting for 22% of new insurance written. This makes the company vulnerable to any relationship deterioration or pricing pressure from rivals like MGIC and Arch Capital. Furthermore, competitors are aggressively deploying AI-driven risk assessment platforms that threaten the value of Genworth's legacy data and operational speed (Source: GuruFocus, Porter's Five Forces Analysis).
Sentiment remains hostile among long-term care policyholders due to Genworth’s 'Multi-Year Action Plan' (MYAP) which relies on aggressive premium hikes. Regulatory pushback is mounting; Massachusetts recently denied a 161% rate increase request, labeling it 'unjust, unfair and inequitable.' Customers are increasingly trapped between unaffordable premiums and reduced benefits, leading to persistent litigation and regulatory scrutiny at the state level (Source: Long Term Care Desk, April 2026).
Full Earnings Call Transcript
Full Earnings Call Transcript — Q1 • 2026-05-06
Operator: Please stand by. We are about to begin. Good morning, ladies and gentlemen, and welcome to Genworth Financial, Inc.'s First Quarter 2026 Earnings Conference Call. My name is Jess, and I will be your coordinator today. As a reminder, the conference is being recorded for replay purposes. We will facilitate a question and answer session towards the end of this conference call. I would now like to turn the presentation over to Christine Jewell, Head of Investor Relations. Please proceed. Christine Jewell: Thank you, and good morning. Welcome to Genworth Financial, Inc.'s First Quarter 2026 Earnings Call. The slide presentation that accompanies this call is available on the Investor Relations section of the Genworth Financial, Inc. website, investor.genworth.com. Our earnings release and financial supplement can also be found there and we encourage you to review these materials. Speaking today will be Tom McInerney, President and Chief Executive Officer, and Jerome Upton, Chief Financial Officer. Following our prepared remarks, we will open the call for questions. In addition to our speakers, Jamala Arland, President and CEO of our Closed Block Insurance business, Greg Caruana, General Counsel, Kelly Saltsgeber, Chief Investment Officer, and Samir Shah, CEO of CareScout, will also be available to take your questions. During this morning's call, we may make various forward-looking statements. Our actual results may differ materially from such statements. We advise you to read the cautionary notes regarding forward-looking statements in our earnings release and related presentation as well as the risk factors of our most recent annual report on Form 10-K as filed with the SEC. Today's discussion also includes non-GAAP financial measures that we believe may be meaningful to investors. In our investor materials, non-GAAP measures have been reconciled to GAAP where required and in accordance with SEC rules. Additionally, references to statutory results are estimates due to the timing of the statutory filing. And now I will turn the call over to our President and CEO, Tom McInerney. Tom McInerney: Thank you, Christine, and thank you all for taking the time to join our first quarter earnings call this morning. In the first quarter, we continued to execute across our strategic priorities and have once again generated strong shareholder value. We advanced our long-term growth strategy through CareScout, and we further strengthened the self-sustainability of our closed block. Before turning to our results, I would like to briefly address an update to how we present and evaluate our core operating earnings. As we have discussed, our closed block of legacy insurance products is separate from our other business lines and self-sustaining, and the quarter-to-quarter GAAP volatility does not reflect the underlying economics or how the business is strategically positioned for the long term. As a result, going forward, we will report Genworth Financial, Inc.'s consolidated adjusted operating income excluding the closed block. We believe this view of our operating performance better aligns with our strategy and capital allocation framework, driving current and future shareholder returns through Enact and long-term growth opportunities with CareScout. We will continue to report the adjusted operating income for the closed block separately in our disclosures. For the first quarter, Genworth Financial, Inc. reported net income of $47 million with adjusted operating income, excluding the closed block, of $109 million. Our results this quarter were led by continued strong performance from Enact, with adjusted operating income of $140 million. The holding company ended the quarter with a solid liquidity position, holding $166 million of cash and liquid assets. Turning to our strategic priorities, I am pleased with our progress as we execute with discipline across the businesses. First, we continue to create shareholder value through Enact's growing market value and capital returns. Our approximately 81% ownership stake in Enact remains a key source of cash flows to Genworth Financial, Inc. and helps fuel our disciplined approach to capital allocation. This strategy includes returning capital to shareholders through share repurchases while also investing in our long-term growth opportunities through CareScout. This balanced approach enables us to drive near-term value while still positioning the company for sustainable long-term growth. In the first quarter, we received $99 million in total capital returns from Enact. Supported by these strong cash flows, we continue to execute on our share repurchase program. Since the initial authorization of our current buyback program, we have bought back a total of $875 million worth of shares at an average price of $6.38 as of April 30, 2026. Turning to our next strategic priority, we continue to drive growth from CareScout, which represents a significant long-term opportunity given the growing demand for aging care, including from 70 million baby boomers now aged 62 to 80 in 2026. We are building a comprehensive aging platform designed to help people understand, find, and fund the quality long-term care they need, all in one place. We do this in three ways. First, comprehensive solutions, providing access to a full suite of services across the aging journey from care planning and guidance to finding providers to funding care. Second, expert guidance, leveraging our data, technology, and decades of claims experience to match individuals with the right care provider options and help them make informed decisions with confidence. And third, technology-enabled human connection, delivering that expertise through trained advisers who provide personalized local support and help families navigate what is often a complex, fragmented, and emotional process. Under Samir Shah's leadership, we are integrating these capabilities across the platform to deliver a seamless experience and build a capital-light, scalable business for long-term growth. During the first quarter, we continued to expand the CareScout Quality Network, or CQN, at an impressive pace across both home care and senior living communities. In the first quarter, we added our first senior living communities to the network. This development marks another important step in broadening access beyond home care and expanding options available to consumers in the marketplace. As we continue to integrate senior living communities from our acquisition of SeniorLeaf, we are building a more comprehensive network that can support people across different stages of the aging journey. By the end of 2026, we anticipate having more than 1,000 home care locations and approximately 2,000 senior living communities as part of the CQN. As a reminder, our revenue model for senior living communities differs from our home care model, with CareScout earning a one-time placement fee upon a successful move-in, consistent with how the broader industry operates. Over time, we expect this to complement our existing home care discount model and contribute to a more diversified, scalable, and substantial stream of revenue in the business. In home care, our network now covers approximately 97% of the U.S. population aged 65 and older. We continue to see strong interest from more providers every day as we expand into additional markets and strengthen coverage in geographies with high demand. As the network grows, we remain focused on optimizing coverage and pricing efficiency while ensuring quality, consistency, and long-term scalability. We facilitated approximately 1,500 matches between care seekers and providers in the first quarter, reflecting strong sequential and year-over-year growth. This was driven in part by the expansion beyond home care matches and into senior living communities. The Q1 figure includes our first direct-to-consumer matches, which we are making in both home care and senior living communities. While quarterly pacing may vary, we are building momentum and remain on track toward our previously discussed target of approximately 7,500 matches in 2026, compared to 3,255 matches in 2025. As our network continues to scale and brand awareness grows, we expect to drive increased traction across the platform. We also expect a higher share of Genworth Financial, Inc. policyholders to utilize CQN providers and benefit from more efficient care coordination by our team, helping to stretch their benefit dollars further while generating claim savings for the closed block over time. We also continue to work with other insurance carriers managing closed LTC blocks to leverage the CareScout Quality Network. Integrating other LTC insurance carriers along with select affinity groups represents an important opportunity to introduce more consumers to the CareScout brand, extend our platform beyond Genworth Financial, Inc., and generate additional fee-based revenues over time. In parallel, we are scaling our fee-for-service offerings that generate recurring revenue streams and create additional pathways for CareScout's growth. Overall, we continue to expect $25 million of CareScout service revenues in 2026, and we are making steady progress towards that goal. Turning to CareScout Insurance, we continue to build out our differentiated product offerings and expand our distribution capabilities. Our new CareAssurance product is clearly differentiated in the LTC insurance market by giving customers and their families access to a more holistic aging experience through our services business, including access to the CareScout Quality Network, wellness support tools, and care planning services. We believe this integrated approach provides a distinct advantage in a market that remains fragmented and very underserved relative to the growing demand for long-term care over time. Looking ahead, we plan to launch our CareAssurance worksite product later this year. The worksite channel will broaden access through employers and associations. We are also developing additional offerings, including hybrid LTC insurance products with innovative designs that pair a minimum LTC benefit with low-cost fixed income and equity accounts designed for accumulation. Hybrid products offer a broader set of funding solutions designed to meet evolving customer needs and solve critical gaps in retirement income and retirement security in the marketplace. As the U.S. population ages, CareScout will continue to broaden its capabilities with a focus on ensuring families can more easily access the support, guidance, and resources they need to navigate the complexities of aging. Turning to our third priority, we continue to actively manage our self-sustaining, customer-centric closed block of LTC, life, and annuity products. This business is being managed with a focus on delivering high-quality policyholder experiences, maintaining capital discipline, and ensuring long-term sustainability as we position Genworth Financial, Inc. for growth through CareScout. Our multiyear rate action plan, or MYRAP, remains our most effective lever for maintaining that sustainability. In the first quarter, we secured $5 million of gross incremental premium approvals. We have built on this progress in the second quarter, already achieving another $45 million. As we enter the later stages of the MYRAP program, we expect premium approvals to be lower and benefit reductions to be higher because the future premium runway is shortened as Genworth Financial, Inc. policyholders age, as shown on Appendix Slide 20. That said, we expect full-year 2026 premium approvals and benefit reductions to be broadly in line with 2025 levels, contributing approximately $1 billion of economic value on a net present value basis. Since the program began in 2012, we have achieved approximately $34.5 billion in net present value through a combination of premium increases and benefit reductions. We remain focused on executing this program with discipline to ensure the long-term self-sustainability of the closed block. Next, I will provide a brief update on the Absa litigation. The appeal hearing is scheduled for July. We expect the Court of Appeal to reach a decision within approximately three to six months of that hearing. If the judgment is ultimately upheld and all appeals are favorably resolved, we expect to recover a total sum of approximately $750 million, subject to exchange rates at that time. We do not expect to pay taxes on this recovery. As we said previously, any potential recoveries are not factored into our capital allocation plans. If proceeds are received, we would deploy them in line with our existing priorities: investing in CareScout, returning capital to shareholders, and reducing debt. Before I turn it over to Jerome, I would like to briefly address the current macroeconomic backdrop. We continue to closely monitor an uncertain and dynamic external environment, including uneven consumer spending and the potential for higher inflation and interest rates. We believe Genworth Financial, Inc. is well positioned to navigate a range of market conditions in 2026 and beyond. Enact continues to operate from a position of strength supported by disciplined underwriting and a strong capital position and provides Genworth Financial, Inc. with strong free cash flow. We continue to integrate new technology and operational capabilities across the organization, enabled by artificial intelligence. We have several AI and generative AI initiatives underway with key partners focused on improving efficiencies in claim management, enhancing the policyholder and customer service experience, and supporting more scalable growth across CareScout. Even as we advance these capabilities, our approach remains grounded in the tech-enabled, human-centered support our policyholders rely on throughout the aging journey. In closing, we are pleased with the progress we have made in the first quarter across our strategic priorities, supported by another quarter of strong performance from Enact. As we move towards the midway point of the year, we remain focused on disciplined execution and building long-term value for our shareholders. And with that, I will turn the call over to Jerome. Jerome Upton: Thank you, Tom, and good morning, everyone. We entered 2026 with strong momentum, and as Tom highlighted, we continued to execute against our strategic priorities while enhancing our financial flexibility and positioning the company for long-term success. Enact's first quarter results reflected continued strategic and operational strength underpinned by its strong balance sheet and liquidity profile that continue to create value and fuel our capital allocation priorities. We also made further progress scaling CareScout and strengthening the self-sustainability of our closed block. I will begin with an overview of our first quarter financial results and key drivers, followed by a discussion of our investment portfolio and holding company liquidity. I will then cover our capital allocation priorities and provide an update on our guidance for 2026 before we open the call for Q&A. Starting with the financial results on Slide 9, as Tom mentioned, going forward, we are updating the presentation of our consolidated earnings to exclude results from our Closed Block segment to better align with our strategy and capital allocation framework managing the closed block on a standalone basis. We will continue to report the adjusted operating income for the closed block separately in our disclosures. First quarter adjusted operating income, excluding the closed block, was $109 million, driven by strong performance in Enact, partially offset by losses in Corporate and Other. Enact delivered another strong quarter of performance with adjusted operating income of $140 million to Genworth Financial, Inc. Results included a pretax reserve release of $39 million reflective of continued strong cure performance. Results are down versus the prior quarter reflecting a lower reserve release and up versus the prior year reflecting increased investment income and favorable expenses. In Corporate and Other, we reported an adjusted operating loss of $31 million for the quarter, reflecting continued investment in CareScout and ongoing holding company debt service. The prior quarter included a benefit from favorable tax-related items. Our Closed Block segment reported an adjusted operating loss of $32 million. This was driven by a liability remeasurement loss related to the actual variances from expected experience, or A to E, of $36 million pretax, primarily in LTC. Our results in LTC were favorably impacted by net insurance recoveries in the quarter of $65 million pretax. Mortality in both LTC and life insurance was seasonally higher sequentially but lower than the prior year. While results can vary quarter to quarter, we expect to see A to E losses in the range of approximately $300 million for the full year 2026. As a reminder, these GAAP fluctuations do not impact our cash flows, economic value, or how we manage the business. Now taking a closer look at Enact's performance underlying its strong financial results beginning on Slide 10, new insurance written of $13 billion in the quarter decreased versus the prior quarter primarily based on seasonal trends but increased versus the prior year as a result of lower interest rates early in the quarter. Primary insurance in force increased year over year to $272 billion supported by the growth in new insurance written and continued elevated persistency. Earned premiums in the quarter were $243 million, down slightly versus the prior quarter and prior year. As shown on Slide 11, Enact's favorable $39 million pretax reserve release drove a loss ratio of 15%. Enact's estimated PMIERs sufficiency ratio remains strong at 162%, or approximately $1.9 billion above requirements. Genworth Financial, Inc.'s share of Enact's book value, including AOCI, was $4.3 billion at the end of the first quarter, down slightly from $4.4 billion at year-end 2025, driven by movements in the market value of the investment portfolio as a result of increased interest rates. While maintaining its strong balance sheet, Enact has continued to deliver significant capital returns to Genworth Financial, Inc. We received $99 million from Enact in the first quarter. Looking ahead, Enact remains well positioned to navigate the current macroeconomic environment supported by its strong balance sheet and disciplined underwriting. Turning to our Closed Block segment on Slide 12, we continue to proactively manage and reduce LTC risk and improve self-sustainability through prudent in-force management, including benefit reductions and premium rate increases. As of the end of the first quarter, we had achieved approximately $34.5 billion of benefit reductions and premium increases on a net present value basis since 2012. As part of our multiyear rate action plan, we offer a suite of options to help policyholders manage premium increases while maintaining meaningful coverage. These benefit solutions enable us to reduce our exposure to certain higher-cost features, such as 5% compound benefit inflation options and large benefit pools. Cumulatively, about 61% of policyholders offered a benefit reduction have elected to take one, lowering our long-term risk. These initiatives have helped reduce our exposure to the riskiest LTC policy features. Notably, our exposure to the 5% compound benefit inflation option has decreased below 36%, down from 57% in 2014, and the percentage of our policies with lifetime benefits has decreased to 11%. We remain committed to managing GLIC and its subsidiaries as a closed system, leveraging their existing reserves and capital to cover future claims. We will not inject capital into these companies and, given the long-tail nature of our LTC insurance policies, with peak claim years still over a decade away, we also do not expect capital returns. Turning to Slide 13, our investment portfolio remains resilient and is conservatively positioned. The majority of our assets are in investment-grade fixed maturities held to support our long-duration liabilities. New money yields continue to exceed those on sales and maturities, with cash in our life insurance companies being invested at yields of approximately 6.3% for the quarter. Our alternative assets program is largely comprised of diversified private equity investments and has targeted returns of approximately 12%. Quarterly realizations fluctuate, with first quarter transactions affected by geopolitical tensions. We remain committed to growing our alternative assets portfolio within regulatory limitations due to its robust track record of returns, diversification benefits, and natural fit with long-term liabilities. Next, turning to the holding company on Slide 14, we ended the quarter with $166 million in cash and liquid assets. When evaluating holding company liquidity for the purpose of capital allocation, and calculating the buffer to our debt service target, we excluded approximately $50 million of cash held for future obligations, including advanced cash payments from our subsidiaries. Moving to capital allocation on Slide 15, our priorities remain unchanged. We will continue to invest in long-term growth through CareScout, return cash to shareholders through our share repurchase program when our share price trades below intrinsic value, and opportunistically retire debt. During the quarter, we repurchased $66 million of shares at an average price of $8.61 per share. We repurchased an additional $19 million through April 30, 2026. We also retired approximately $5 million of principal debt in the quarter, bringing our holding company debt down to $778 million. We maintain a disciplined capital structure with a cash interest coverage ratio on debt service of approximately nine times. I will now turn to our outlook for 2026 and provide an update on the guidance we shared in February on our fourth quarter earnings call. As announced yesterday, Enact has increased its quarterly dividend and continues to expect to return approximately $500 million of capital to its shareholders in 2026. Based on our approximate 81% ownership position, we continue to expect to receive around $405 million to $450 million from Enact for the full year. Second, we continue to create value for our shareholders through our share repurchase program. For the full year 2026, we now expect to allocate between $195 million and $225 million to share repurchases. As we have said before, this range may vary depending on market conditions, business performance, holding company cash, and our share price. Third, turning to CareScout. As Tom indicated, in the services business, we continue to target approximately 7,500 matches in 2026, including matches across both home care providers and senior living communities. CareScout services generated $6 million in revenue in the first quarter, and we continue to expect revenue in this business of $25 million for the full year. We plan to invest approximately $50 million to $55 million in services in 2026 as we continue scaling the business and expanding its reach. These investments will support the continued build-out of our technology platform, the addition of new products and care settings, and growth across both consumer and B2B channels. We are also deepening carrier partnerships and enhancing operational infrastructure to support higher volumes, recurring revenue, and long-term scalability. For insurance, we currently do not expect any additional investments in 2026 following our $85 million investment to launch our inaugural product last year. As we expand our product suite, grow our distribution network and sales levels, and refine our operating platform, we will make appropriate investments in the business. We have made good progress overall with CareScout and remain confident in its continued growth in 2026. As we have noted previously, scaling these businesses and achieving breakeven will take time. In closing, we are delivering on our strategic priorities and enhancing financial flexibility while proactively managing our liabilities and risk. Our focus remains on driving durable growth through Enact and CareScout, which serve as a foundation of our long-term value creation strategy. At the same time, we are strengthening the self-sustainability of our closed block, maintaining our commitment to return capital to shareholders through share repurchases, and opportunistically retiring debt. These actions position Genworth Financial, Inc. to deliver long-term value for our shareholders. We will now open the call for questions. Now, let us open up the line for questions. Thank you. Operator: Ladies and gentlemen, we will now begin the Q&A portion of the call. As a reminder, please refrain from using cell phones, speakerphones, or headsets. Please press star 1 to ask a question. We will go first to a question from Joshua Estrach with Credit Insights. Your line is open. Please go ahead. Analyst: Hey. Good morning, folks. Thanks for taking my question. So, modest decline in the estimated RBC ratio at GLIC at quarter-end, and I know you folks have been adamant for years that no capital contributions to life entities are planned. But I am wondering if there is, like, a specific RBC ratio level at which you would either be forced or consider contributing capital, or, you know, alternatively, if there is a lever you can pull to bolster RBC in the life units to the extent it becomes necessary without a capital contribution. Tom McInerney: Thank you for your question, Josh. Our target is to have RBC at $250 million or more, and so we are very comfortable with where we are. Obviously, the RBC did go down in the first quarter because of the statutory loss, but that is why we have quite a bit of room. There is no requirement from a regulatory perspective. I mean, we are well above, at almost three times required capital, what the regulators require. Jerome Upton: Josh, good morning. Thanks for the question. Look, we felt some pressure in the first quarter, as Tom indicated, down to 2.89. That is still a good ratio. We did see mortality; it went up in the quarter, but it certainly was not at the level that we would have expected. I think that impacted LTC, but I believe that was felt across the industry as well. We also saw some life pressure from our post-level term block coming through and some reserve build. We do not expect that to continue. What I would highlight to you is we are going to continue to execute our strategy. That strategy and our statutory results are premised upon our ability to get the multiyear rate action plan, which, as Tom highlighted, has been very successful, our benefit solutions, and our Live Well, Age Well program as well as our CareScout Quality Network. We are active in achieving those benefits, and those will be key drivers of our RBC and our statutory results going forward. Operator: Thank you very much. Analyst: And if you do not mind, maybe I can sneak in one more here and pivot a little bit. I appreciate the color and the commentary you gave earlier on the investment portfolio front, but if maybe you can give a little bit more detailed color on the private credit portfolio, maybe even just at a high level, the characteristics either from a ratings or asset class or sector basis, and maybe you can just briefly tell us how you perhaps source the investments or any of the partnerships you might have to bolster your private credit capabilities. Jerome Upton: Sure. Thanks for the question. Kelly is on the call, so we will ask Kelly to comment. Kelly Saltsgeber: Yes, thanks, Josh, for the question. Private credit has been referred to in the media of late really as what we call direct lending or middle market loans, which are private loans to small companies, and we have very minimal exposure there. We have about 1% of our portfolio in middle market loans, and we access that market through a well-regarded and experienced manager through a separately managed account. Our direct lending portfolio actually has no exposure to what is classified as the software category, and so it is very different from what you are reading about with some of the BDCs. Now, we have other private investments. We have been in the private placement market for decades, and that is an investment-grade portfolio. We also have recently started accessing private asset-based finance, also primarily through external managers, and that is an investment-grade mandate with an average rating of single-A or triple-B. We also access the private equity market mainly through advisers that are very experienced in the space, including Neuberger and JPMorgan. I would say our private exposure is almost exclusively investment grade with the exception of the 1% in middle market loans that I mentioned. Analyst: Got it. Thank you very much. I appreciate everyone's time this morning. Jerome Upton: Thanks, Josh. Operator: Once again, ladies and gentlemen, it is star 1 if you have a question. It appears there are no questions at this time. Ladies and gentlemen, I will now turn the call back over to Mr. McInerney for closing comments. Tom McInerney: Thank you all very much for joining the call today and for your continued support and interest in Genworth Financial, Inc. At this point, I will turn the call back over to Jess to have her close it. Operator: Thank you, sir. Ladies and gentlemen, that will conclude the call. We thank you for your participation. You may disconnect at this time.